Calcium Carbonate-Based Mucoadhesive Microcontainers for Intranasal Delivery of Drugs Bypassing the Blood–Brain Barrier

被引:27
|
作者
Borodina T.N. [1 ]
Trushina D.B. [1 ,2 ,3 ]
Marchenko I.V. [1 ,3 ]
Bukreeva T.V. [1 ,3 ]
机构
[1] Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics” of Russian Academy of Sciences, Leninskii pr. 59, Moscow
[2] Faculty of Physics, Lomonosov Moscow State University, Leninskie Gory 1, b.2, Moscow
[3] National Research Centre “Kurchatov Institute”, pl. Akademika Kurchatova 1, Moscow
基金
俄罗斯基础研究基金会;
关键词
Anesthetic; Avoidance of blood–brain barrier; Calcium carbonate microparticles; Drug delivery; Intranasal administration; Microcontainers; Mucoadhesive polymer;
D O I
10.1007/s12668-016-0212-2
中图分类号
学科分类号
摘要
There is an opinion in the medical associations that intranasal administration of medicine allows direct olfactory transfer of drugs into the central nervous system bypassing the blood–brain barrier. This approach could be a valuable solution to the problem of cerebral pathology treatment. We propose a new system of microcontainers for the delivery of an active component to the brain by intranasal administration. The microcontainers were fabricated on the base of porous calcium carbonate particles modified with mucoadhesive biocompatible polymer or polymer/surfactant coating. Loperamide was encapsulated in the proposed microcontainers as a model drug, which cannot pass the blood–brain barrier. The efficiency of microcontainers loaded with the anesthetic loperamide has been assessed by the formalin test in rats in vivo. The results of the in vivo experiments demonstrate decrease in the pain sensitivity after intranasal administration of proposed system, and benefit of mucoadhesive biocompatible coating aiming to improve the anesthetic effect. © 2016, Springer Science+Business Media New York.
引用
收藏
页码:261 / 268
页数:7
相关论文
共 50 条
  • [31] Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas
    Huang, Xin
    Shi, Shuyou
    Wang, Hongrui
    Zhao, Tiesuo
    Wang, Yibo
    Huang, Sihua
    Su, Yingying
    Zhao, Chunyan
    Yang, Ming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
  • [32] Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood-Brain Barrier to Treat Brain Tumors
    Vanbilloen, Wouter J. F.
    Rechberger, Julian S.
    Anderson, Jacob B.
    Nonnenbroich, Leo F.
    Zhang, Liang
    Daniels, David J.
    PHARMACEUTICS, 2023, 15 (07)
  • [33] Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma
    Oberoi, Rajneet K.
    Parrish, Karen E.
    Sio, Terence T.
    Mittapalli, Rajendar K.
    Elmquist, William F.
    Sarkaria, Jann N.
    NEURO-ONCOLOGY, 2016, 18 (01) : 27 - 36
  • [34] The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret, Ludenne
    DRUG DISCOVERY TODAY, 2008, 13 (23-24) : 1099 - 1106
  • [35] The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier
    Barbu, Eugen
    Molnar, Eva
    Tsibouklis, John
    Gorecki, Dariusz C.
    EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (06) : 553 - 565
  • [36] Peptide-Based Delivery of Oligonucleotides Across Blood–Brain Barrier Model
    Artita Srimanee
    Jakob Regberg
    Mattias Hallbrink
    Kaido Kurrikoff
    Kadi-Liis Veiman
    Opa Vajragupta
    Ülo Langel
    International Journal of Peptide Research and Therapeutics, 2014, 20 : 169 - 178
  • [37] Blood-Brain Barrier Disruption with Focused Ultrasound Enhances Delivery of Chemotherapeutic Drugs for Glioblastoma Treatment
    Liu, Hao-Li
    Hua, Mu-Yi
    Chen, Pin-Yuan
    Chu, Po-Chun
    Pan, Chia-Hsin
    Yang, Hung-Wei
    Huang, Chiung-Yin
    Wang, Jiun-Jie
    Yen, Tzu-Chen
    Wei, Kuo-Chen
    RADIOLOGY, 2010, 255 (02) : 415 - 425
  • [38] Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
    Leah R Hanson
    William H Frey
    BMC Neuroscience, 9
  • [39] Intranasal delivery of nerve growth factor bypasses the blood-brain barrier and protects against acute ischemic damage.
    Liu, XF
    Zhao, HM
    Mao, XW
    STROKE, 2004, 35 (01) : 279 - 279
  • [40] Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
    Hanson, Leah R.
    Frey, William H., II
    BMC NEUROSCIENCE, 2008, 9 (Suppl 3)